英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
677021查看　677021　在百度字典中的解释百度英翻中〔查看〕
677021查看　677021　在Google字典中的解释Google英翻中〔查看〕
677021查看　677021　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Press releases - Angelini Pharma
    The transaction is part of Angelini Pharma's global development strategy of maintaining a focus on consumer healthcare and investing in specialty care with particular reference to Brain Health
  • Annual Report - Angelini Industries
    products, solutions, and services that improve automation and production processes for a wide range of products, such as: disposable sanitary pad products for personal hygiene, personal and home care products, pods and single-dose detergents, disposable first aid devices and products (e g , band-aids), liquid bottling, sustainable packaging
  • Dr. Vicente Villanueva and new Freedon study
    Dr Vicente Villanueva – What does Freedon Study tell us? Real-life outcomes of cenobamate in different lines of treatment Cenobamate is a promising treatment option for adults with uncontrolled focal seizures, demonstrating significant seizure freedom rates in pivotal trials Its efficacy was established in two studies, C013 and C017—randomized, double-blind, placebo-controlled trials
  • ONTOZRY® (Cenobamate) Efficacy | Angelini Pharma Ltd
    Explore ONTOZRY® (cenobamate) efficacy data, including clinical trial results, to aid safe prescribing and support sustained seizure control For UK-I HCPs
  • Headway 2023 - Europe - Angelini Pharma
    The following report has been elaborated by The European House – Ambrosetti Team (Daniela Bianco – Partner and Head of Healthcare Area, The European House – Ambrosetti), Elisa Milani (“Headway 2023” Project Coordinator and Consultant, The European House – Ambrosetti), Irene Gianotto (Consultant, The European House – Ambrosetti) and Clara Morelli (Analyst, The European House
  • Harmonia Mentis | The Project
    Harmonia Mentis is Angelini Pharma's web portal dedicated to brain health topics, available in 22 countries Discover HarmoniaMentis com and join our mission to promote better understanding and support for brain health worldwide
  • Amuchina and Infasil: brand transfer from Angelini Pharma to Fater
    The transaction is part of Angelini Pharma's global development strategy of maintaining a focus on consumer healthcare and investing in specialty care with particular reference to Brain Health
  • Erik Lommerde - Leadership Team | Angelini Pharma
    His academic background includes a Master’s in Medical Biology Biochemistry from the University of Amsterdam and an MBA from the Rotterdam School of Management He is married and has three children Together with his family, he supports a dog sanctuary north of Madrid that offers a final home to dogs coming from long-term shelter conditions
  • Angelini Pharma acquires Arvelle Therapeutics
    Angelini Pharma and Arvelle Therapeutics have today agreed on a definitive merger agreement valuing Arvelle Therapeutics at up to $960 million Angelini Pharma will become a leading player amongst companies focused on Central Nervous System (CNS) and mental health disorder treatments Opening direct affiliates in France, UK, Nordics and Switzerland by 2022 Rome, January 4, 2021 - Angelini Pharma





中文字典-英文字典  2005-2009